Integra LifeSciences (IART) Reports Prelim. Q4 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Integra LifeSciences Announces Preliminary Fourth Quarter 2017 Financial Results
January 8, 2018 6:30 AM ESTPreliminary Fourth Quarter Highlights:
Fourth quarter 2017 reported revenue is expected to be approximately $365 million, exceeding the high-end of the companys previous implied guidance range of $345 million to $355 million;Organic revenue growth in the fourth quarter is expected to be about 5.5%, above the companys implied guidance of about 4%;The Company is still evaluating the impact of the Tax Cuts and Jobs Act of 2017 on its GAAP financial results;Fourth quarter 2017 adjusted earnings per share, excluding any impact from the Tax Cuts and Jobs Act of 2017, is expected to exceed the... More


